CCMH
SGYP

Cornerstone Capital Management Holdings’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$354K Sell
159,059
-35,300
-18% -$87.8K ﹤0.01% 1052
2017
Q3 		$562K Buy
194,359
+61,200
+46% +$209K ﹤0.01% 1040
2017
Q2 		$591K Buy
133,159
+26,712
+25% +$110K ﹤0.01% 1016
2017
Q1 		$496K Buy
+106,447
New +$617K ﹤0.01% 1063

Other funds holding SGYP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Cornerstone Capital Management Holdings's SGYP Position: Q4 2017 in Review

Cornerstone Capital Management Holdings reduced its Synergy Pharmaceuticals, Inc Common Stock (SGYP) stake by 18% in Q4 2017, selling an estimated $87.8K and leaving 159,059 shares worth $354K. The position accounts for ﹤0.01% of the portfolio, ranked #1052.

Cornerstone Capital Management Holdings first reported a position in SGYP in Q1 2017 and has held it in 4 quarters since. The position peaked at $591K in Q2 2017. 149 funds tracked by Wall St. Rank hold SGYP as of Q4 2017.

  • Cornerstone Capital Management Holdings held 159,059 shares of Synergy Pharmaceuticals, Inc Common Stock worth $354K as of Q4 2017.
  • Cornerstone Capital Management Holdings sold 35,300 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2017, an estimated $87.8K.
  • Synergy Pharmaceuticals, Inc Common Stock made up ﹤0.01% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #1052 holding.
  • Cornerstone Capital Management Holdings first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q1 2017 and has held it in 4 quarters since.
  • Cornerstone Capital Management Holdings's Synergy Pharmaceuticals, Inc Common Stock position peaked at $591K in Q2 2017.
  • 149 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.